Back
Protagonist Therapeutics Vs. Gorman-Rupp Industry Stock Comparison
Buy
56
PTGX
Protagonist Therapeutics
Last Price:
25.76
Seasonality Move:
34.23%
Buy
68
GRC
Gorman-Rupp
Last Price:
33.11
Seasonality Move:
2.86%
Buy
56
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $26.06. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Gorman-Rupp (GRC)
is a Buy
Is Gorman-Rupp a Buy, Sell or Hold?
- The current Gorman-Rupp [GRC] share price is $32.79. The Score for GRC is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- GRC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $26.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing slight buying pressure.
GRC Stock Price Chart
What is Gorman-Rupp's stock price today?
-
The Gorman-Rupp share price today is $32.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRC is experiencing selling pressure, which indicates risk of future bearish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 46.52 | Sell |
| Chaikin Money Flow: | 50618 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.34 - 27.74) | Sell |
| Bollinger Bands (100): | (23.57 - 29.09) | Sell |
GRC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.3 | Sell |
| Relative Strength Index (14 RSI): | 33.96 | Sell |
| Chaikin Money Flow: | -91249 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.51 - 38.09) | Sell |
| Bollinger Bands (100): | (33.66 - 37.68) | Sell |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.46 | Buy |
| 20-day SMA: | 26.18 | Sell |
| 50-day SMA: | 28.05 | Sell |
| 200-day SMA: | 21.96 | Buy |
| 8-day EMA: | 25.77 | Buy |
| 20-day EMA: | 26.22 | Sell |
| 50-day EMA: | 26.76 | Sell |
| 200-day EMA: | 23.63 | Buy |
GRC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.73 | Buy |
| 20-day SMA: | 35.11 | Sell |
| 50-day SMA: | 36.67 | Sell |
| 200-day SMA: | 33.59 | Sell |
| 8-day EMA: | 33.26 | Sell |
| 20-day EMA: | 34.68 | Sell |
| 50-day EMA: | 35.72 | Sell |
| 200-day EMA: | 33.65 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.23 per share.
Gorman-Rupp Earnings Growth & GRC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.08 per share, an increase this year of $0.27 per share, and an increase next year of $0.32 per share.
Protagonist Therapeutics Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gorman-Rupp Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||